HKEX:0512 Short term 20 days. Potential profit 11%HKEX:512
Buy in at 5.21
Cut loss at 4.98
Target at 5.79
LongNext report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.075620 USD
317.63 M USD
1.50 B USD
1.05 B
About Grand Pharmaceutical Group Limited
Sector
Industry
CEO
Chao Zhou
Website
Headquarters
Hong Kong
Founded
1995
IPO date
Dec 19, 1995
Identifiers
3
ISIN BMG210A71016
Grand Pharmaceutical Group Ltd. is an investment holding company, which engages in the development, manufacture and distribution of pharmaceutical products. Its products offer ophthalmic medicines for anti-bacterial, antibiotics, antipyretic and analgesic use. It operates through the following geographical segments: The People's Republic of China (PRC), America, Europe, Asia other than the PRC, and Others. The company was founded on October 18, 1995 and is headquartered in Hong Kong.
Related stocks
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
513120
GF CSI Hong Kong Brand Name Drug Exchange Traded Fund UnitsWeight
1.44%
Market value
27.32 M
USD
159892
ChinaAMC Hang Seng Hong Kong-Listed Biotech Index ETF Units AWeight
1.29%
Market value
8.20 M
USD
159567
Yinhua China Sec Hong Kong Stock Connect Innovative Drug EtfWeight
1.35%
Market value
5.59 M
USD
513200
E Fund CSI HK Connect Health Care Composite Exchange Traded Fund UnitsWeight
1.07%
Market value
3.39 M
USD
Explore more ETFs
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange GRAND PHARMACEUTICAL GROUP LIMITED stocks are traded under the ticker CGPHF.
We've gathered analysts' opinions on GRAND PHARMACEUTICAL GROUP LIMITED future price: according to them, CGPHF price has a max estimate of 1.53 USD and a min estimate of 1.53 USD. Watch CGPHF chart and read a more detailed GRAND PHARMACEUTICAL GROUP LIMITED stock forecast: see what analysts think of GRAND PHARMACEUTICAL GROUP LIMITED and suggest that you do with its stocks.
Yes, you can track GRAND PHARMACEUTICAL GROUP LIMITED financials in yearly and quarterly reports right on TradingView.
GRAND PHARMACEUTICAL GROUP LIMITED is going to release the next earnings report on Mar 18, 2026. Keep track of upcoming events with our Earnings Calendar.
CGPHF net income for the last half-year is 148.87 M USD, while the previous report showed 117.15 M USD of net income which accounts for 27.08% change. Track more GRAND PHARMACEUTICAL GROUP LIMITED financial stats to get the full picture.
Yes, CGPHF dividends are paid annually. The last dividend per share was 0.03 USD. As of today, Dividend Yield (TTM)% is 3.44%. Tracking GRAND PHARMACEUTICAL GROUP LIMITED dividends might help you take more informed decisions.
GRAND PHARMACEUTICAL GROUP LIMITED dividend yield was 5.42% in 2024, and payout ratio reached 36.88%. The year before the numbers were 6.36% and 48.51% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Feb 14, 2026, the company has 11.99 K employees. See our rating of the largest employees — is GRAND PHARMACEUTICAL GROUP LIMITED on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GRAND PHARMACEUTICAL GROUP LIMITED EBITDA is 289.73 M USD, and current EBITDA margin is 21.87%. See more stats in GRAND PHARMACEUTICAL GROUP LIMITED financial statements.
Like other stocks, CGPHF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GRAND PHARMACEUTICAL GROUP LIMITED stock right from TradingView charts — choose your broker and connect to your account.